Bio: Rakesh Nagarajan is a founder and the Chief Executive Officer (CEO) at PierianDx. Dr. Nagarajan is trained as a physician-scientist with deep experience in molecular biology, molecular laboratory workflows and techniques. His multiple informatics subspecialties include bioinformatics, biospecimen informatics, clinical trials informatics, and medical informatics. He currently serves on the College of American Pathologists (CAP) Molecular Oncology Committee and the Next-Generation Sequencing (NGS) Project Team and is a molecular pathology specialty inspector for the CAP. He is also an Adjunct Associate Professor at the Washington University School of Medicine Department of Pathology & Immunology.
Dr. Nagarajan was formerly an Associate Professor at the Washington University School of Medicine (WUSM) Department of Pathology & Immunology and Genetics and directed the Alvin J. Siteman Cancer Center Bioinformatics Core and the Washington University Clinical and Translational Science Award (CTSA) Biomedical Informatics Program.
From 2003-2015, Dr. Nagarajan and his group developed and supported broad biomedical informatics infrastructure to facilitate clinical and translational research and to support clinical genomic testing. With more than 50 peer-reviewed publications, his laboratory collaborated on numerous clinical and genomic projects by leading in silico analyses of diverse complex disease data sets.